发明授权
US07351720B2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
有权
作为趋化因子受体活性的调节剂的N-脲基烷基 - 哌啶
- 专利标题： N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
- 专利标题（中）： 作为趋化因子受体活性的调节剂的N-脲基烷基 - 哌啶
-
申请号： US10865417申请日： 2004-06-10
-
公开(公告)号： US07351720B2公开(公告)日： 2008-04-01
- 发明人: Soo S. Ko , George V. Delucca
- 申请人： Soo S. Ko , George V. Delucca
- 申请人地址： US NJ Princeton
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 当前专利权人地址： US NJ Princeton
- 代理商 Mary K. VanAtten
- 主分类号： A61K31/4535
- IPC分类号： A61K31/4535 ; C07D417/02
摘要：
The present application describes modulators of chemokine receptor activity of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis, including methods of preparing and intermediates thereof.
公开/授权文献
信息查询
IPC分类:
